Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip.

Janet Conway, Ronald E Delanois + Show 14 more

https://doi.org/10.1128/aac.00655-24

Copy DOI

Publication Date: Jul 16, 2024

Abstract

This study is registered with ClinicalTrials.gov as NCT04763759.

Full Text

Paper version not known

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author